[
  {
    "ts": null,
    "headline": "Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M",
    "summary": "The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising cancer cases and demand for effective chronic disease treatments. Emerging economies show potential for growth, propelled by an increasing need for tissue engineering and organ transplantation solutions. Regenerative Medicine Market Regenerative Medicine Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The \"Regenerative Medicine Market - Global Industry Size, Share, Trends, Opp",
    "url": "https://finnhub.io/api/news?id=37e0d4c7fb3ce432c18ad6cffe95be8b0cfb4663745f99d33e8ea2fda70a23c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762871460,
      "headline": "Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M",
      "id": 137448950,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising cancer cases and demand for effective chronic disease treatments. Emerging economies show potential for growth, propelled by an increasing need for tissue engineering and organ transplantation solutions. Regenerative Medicine Market Regenerative Medicine Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The \"Regenerative Medicine Market - Global Industry Size, Share, Trends, Opp",
      "url": "https://finnhub.io/api/news?id=37e0d4c7fb3ce432c18ad6cffe95be8b0cfb4663745f99d33e8ea2fda70a23c2"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet price target lowered to $93 from $101 at Canaccord",
    "summary": "Canaccord lowered the firm’s price target on Zimmer Biomet (ZBH) to $93 from $101 and keeps a Hold rating on the shares. The firm updated its model following Q3 results and subsequent 10Q release. They noted the company tightened its guidance and reiterated reported growth of 6.7-7.7% with the FNA acquisition expected to contribute roughly 270bps to growth. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommend",
    "url": "https://finnhub.io/api/news?id=a83617e9238f89a731d5260a6dee83ef277072798e0c22d03f9d987b8eb96d98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762862139,
      "headline": "Zimmer Biomet price target lowered to $93 from $101 at Canaccord",
      "id": 137449300,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Canaccord lowered the firm’s price target on Zimmer Biomet (ZBH) to $93 from $101 and keeps a Hold rating on the shares. The firm updated its model following Q3 results and subsequent 10Q release. They noted the company tightened its guidance and reiterated reported growth of 6.7-7.7% with the FNA acquisition expected to contribute roughly 270bps to growth. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommend",
      "url": "https://finnhub.io/api/news?id=a83617e9238f89a731d5260a6dee83ef277072798e0c22d03f9d987b8eb96d98"
    }
  },
  {
    "ts": null,
    "headline": "2 S&P 500 Stocks Worth Your Attention and 1 We Turn Down",
    "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
    "url": "https://finnhub.io/api/news?id=a6b73465a70975df18940f4025343828cfe7c9b5e4de5c9c1545f8b9d4435c7d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762835885,
      "headline": "2 S&P 500 Stocks Worth Your Attention and 1 We Turn Down",
      "id": 137448834,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
      "url": "https://finnhub.io/api/news?id=a6b73465a70975df18940f4025343828cfe7c9b5e4de5c9c1545f8b9d4435c7d"
    }
  }
]